Arizona Fifty-fifth Legislature - Second Regular Session Status: Enacted

HB 2253 — asbestos claims; required information; liability.

Last action — Signed by Governor

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed House
  4. ✓
    Passed Senate
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced January 24, 2022. Enacted.

Odds of enactment

High chance

Based on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Advancing 54% · moderate confidence

  • Enacted

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

  • Mixed recorded votes

    3 passed, 3 failed in recorded votes so far.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Bill Text

What changed in the latest version

792 added · 47 removed

Plain-language change summary

The recent amendment to House Bill 2253 has focused on clarifying the legal definitions within Arizona's drug offenses, particularly in relation to fentanyl. The amendment removed previous provisions regarding asbestos liability claims, indicating a shift in focus towards enhancing drug-related legislation. This change is important because it aims to address the growing concerns surrounding fentanyl, a potent substance that poses significant risks to public health and safety. By refining definitions in drug law, the state can more effectively manage and enforce regulations related to drug offenses.

→
Previous
Latest
House Engrossed asbestos claims;
Senate Engrossed House Bill asbestos claims;
State of Arizona House of Representatives Fifty-fifth Legislature Second Regular Session HOUSE BILL 2253 AN ACT AMENDING TITLE 12, CHAPTER 6, ARTICLE 19, ARIZONA REVISED STATUTES, BY ADDING SECTION 12-783;
(now:
RELATING TO ASBESTOS LIABILITY.
threshold amount;
fentanyl) State of Arizona House of Representatives Fifty-fifth Legislature Second Regular Session CHAPTER 371 HOUSE BILL 2253 AN ACT AMENDING SECTION 13-3401, ARIZONA REVISED STATUTES;
RELATING TO DRUG OFFENSES.
Title 12, chapter 6, article 19, Arizona Revised Statutes, is amended by adding section 12-783, to read:
Section 13-3401, Arizona Revised Statutes, is amended to read:
12-783.
13-3401.
Asbestos personal injury claim;
Definitions In this chapter, unless the context otherwise requires:
sworn statement;
required information;
dismissal;
definition A.
IN ANY ACTION INVOLVING A PERSONAL INJURY CLAIM ARISING FROM EXPOSURE TO ASBESTOS AND IN ADDITION TO ANY REQUIREMENTS FOR ASBESTOS EXPOSURE RELATED CLAIMS PRESCRIBED IN SECTION 12-782, A PLAINTIFF SHALL FILE A SWORN STATEMENT WITHIN FORTY-FIVE DAYS AFTER ANY ASBESTOS ACTION IS FILED.
THE SWORN STATEMENT SHALL SPECIFY THE FACTS THAT PROVIDE THE BASIS FOR EACH CLAIM AGAINST EACH DEFENDANT AND SHALL INCLUDE ALL OF THE FOLLOWING WITH SPECIFICITY:
THE NAME, ADDRESS, DATE OF BIRTH, MARITAL STATUS, OCCUPATION, SMOKING HISTORY, CURRENT AND PAST WORKSITES AND CURRENT AND PAST EMPLOYERS FOR THE EXPOSED PERSON AND ANY PERSON THROUGH WHOM THE EXPOSED PERSON WAS EXPOSED TO ASBESTOS.
"Administer" means to apply, inject or facilitate the inhalation or ingestion of a substance to the body of a person.
EACH PERSON WHO IS KNOWLEDGEABLE REGARDING THE PLAINTIFF'S EXPOSURES.
"Amidone" means any substance identified chemically as (4-4-diphenyl-6-dimethylamine-heptanone-3), or any salt of such substance, by whatever trade name designated.
EACH ASBESTOS-CONTAINING PRODUCT TO WHICH THE PERSON WAS EXPOSED OR THE OTHER PERSON WAS EXPOSED IF EXPOSURE WAS THROUGH ANOTHER PERSON.
"Board" means the Arizona state board of pharmacy.
THE IDENTITY OF THE MANUFACTURER OR SELLER OF THE SPECIFIC ASBESTOS PRODUCT FOR EACH EXPOSURE.
"Cannabis" means the following substances under whatever names they may be designated:
(a) The resin extracted from any part of a plant of the genus cannabis, and every compound, manufacture, salt, derivative, mixture or preparation of such plant, its seeds or its resin.
Cannabis does not include oil or cake made from the seeds of such plant, any fiber, compound, manufacture, salt, derivative, mixture or preparation of the mature stalks of such plant except the resin extracted from the stalks or any fiber, oil or cake or the sterilized seed of such plant which is incapable of germination.
(b) Every compound, manufacture, salt, derivative, mixture or preparation of such resin or tetrahydrocannabinol.
THE SPECIFIC LOCATION AND MANNER OF EACH EXPOSURE, INCLUDING FOR ANY PERSON THROUGH WHOM THE EXPOSED PERSON WAS EXPOSED TO ASBESTOS.
"Coca leaves" means cocaine, its optical isomers and any compound, manufacture, salt, derivative, mixture or preparation of coca leaves, except derivatives of coca leaves which do not contain cocaine, ecgonine or substances from which cocaine or ecgonine may be synthesized or made.
THE BEGINNING AND ENDING DATES OF EACH EXPOSURE AND THE FREQUENCY OF EACH EXPOSURE INCLUDING FOR ANY PERSON THROUGH WHOM THE EXPOSED PERSON WAS EXPOSED TO ASBESTOS.
"Dangerous drug" means the following by whatever official, common, usual, chemical or trade name designated:
(a) Any material, compound, mixture or preparation that contains any quantity of the following hallucinogenic substances and their salts, isomers, whether optical, positional or geometric, and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:
(i) Alpha-ethyltryptamine.
(ii) Alpha-methyltryptamine.
(iii) (2-aminopropyl) benzofuran (APB).
(iv) (2-aminopropyl)-2, 3-dihydrobenzofuran (APDB).
(v) Aminorex.
(vi) 4-bromo-2, 5-dimethoxyphenethylamine.
(vii) 4-bromo-2, 5-dimethoxyamphetamine.
(viii) Bufotenine.
- 1 - H.B.
2253 (ix) [3-(3-carbamoylphenyl)phenyl]N-cyclohexyl carbamate (URB-597).
(x) Diethyltryptamine.
(xi) 2, 5-dimethoxyamphetamine.
(xii) Dimethyltryptamine.
(xiii) (2-ethylaminopropyl)-benzofuran (EAPB).
(xiv) 5-methoxy-alpha-methyltryptamine.
(xv) 5-methoxy-3, 4-methylenedioxyamphetamine.
Show all 500 changed rows (460 more)
Previous
Latest
(xvi) 4-methyl-2, 5-dimethoxyamphetamine.
(xvii) (2-methylaminopropyl)-benzofuran (MAPB).
(xviii) Ibogaine.
(xix) Lysergic acid amide.
(xx) Lysergic acid diethylamide.
(xxi) Mescaline.
(xxii) 4-methoxyamphetamine.
(xxiii) Methoxymethylenedioxyamphetamine (MMDA).
(xxiv) Methylenedioxyamphetamine (MDA).
(xxv) 3, 4-methylenedioxymethamphetamine.
(xxvi) 3, 4-methylenedioxy-N-ethylamphetamine.
(xxvii) N-ethyl-3-piperidyl benzilate (JB-318).
(xxviii) N-hydroxy-3, 4-methylenedioxyamphetamine.
(xxix) N-methyl-3-piperidyl benzilate (JB-336).
(xxx) N-methyltryptamine mimetic substances that are any substances derived from N-methyltryptamine by any substitution at the nitrogen, any substitution at the indole ring, any substitution at the alpha carbon, any substitution at the beta carbon or any combination of the above.
N-methyltryptamine mimetic substances do not include melatonin (5-methoxy n-acetyltryptamine).
Substances in the N-methyltryptamine generic definition include AcO-DMT, Baeocystine, Bromo-DALT, DiPT, DMT, DPT, HO-DET, HO-DiPT, HO-DMT, HO-DPT, HO-MET, MeO-DALT, MeO-DET, MeO-DiPT, MeO-DMT, MeO-DPT, MeO-NMT, MET, NMT and Norbufotenin.
(xxxi) N-(1-phenylcyclohexyl) ethylamine (PCE).
(xxxii) Nabilone.
(xxxiii) 1-(1-phenylcyclohexyl) pyrrolidine (PHP).
(xxxiv) 1-(1-(2-thienyl)-cyclohexyl) piperidine (TCP).
(xxxv) 1-(1-(2-thienyl)-cyclohexyl) pyrrolidine.
(xxxvi) Para-methoxyamphetamine (PMA).
(xxxvii) Psilacetin.
(xxxviii) Psilocybin.
(xxxix) Psilocyn.
(xl) Synhexyl.
(xli) Trifluoromethylphenylpiperazine (TFMPP).
(xlii) Trimethoxyamphetamine (TMA).
(xliii) 1-pentyl-3-(naphthoyl)indole (JWH-018 and isomers).
(xliv) 1-butyl-3-(naphthoyl)indole (JWH-073 and isomers).
(xlv) 1-hexyl-3-(naphthoyl)indole (JWH-019 and isomers).
- 2 - H.B.
2253 (xlvi) 1-pentyl-3-(4-chloro naphthoyl)indole (JWH-398 and isomers).
(xlvii) 1-(2-(4-(morpholinyl)ethyl))-3-(naphthoyl)indole (JWH-200 and isomers).
(xlviii) 1-pentyl-3-(methoxyphenylacetyl)indole (JWH-250 and isomers).
(xlix) (2-methyl-1-propyl-1H-indol-3-YL)-1-naphthalenyl-methanone (JWH-015 and isomers).
(l) (6AR, 10AR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan2- YL)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol) (HU-210).
(li) 5-(1,1-dimethylheptyl)-2-(3-hydroxycyclohexyl)-phenol (CP 47,497 and isomers).
(lii) 5-(1,1-dimethyloctyl)-2-(3-hydroxycyclohexyl)-phenol (cannabicyclohexanol, CP-47,497 C8 homologue and isomers).
(b) Any material, compound, mixture or preparation that contains any quantity of cannabimimetic substances and their salts, isomers, whether optical, positional or geometric, and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation.
For the purposes of this subdivision, "cannabimimetic substances" means any substances within the following structural classes:
(i) 2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position of the phenolic ring by alkyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent.
Substances in the 2-(3-hydroxycyclohexyl)phenol generic definition include CP-47,497, CP-47,497 C8-Homolog, CP-55,940 and CP-56,667.
(ii) 3-(naphthoyl)indole or 3-(naphthylmethane)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent.
Substances in the 3-(naphthoyl)indole generic definition include AM-678, AM-2201, JWH-004, JWH-007, JWH-009, JWH-015, JWH-016, JWH-018, JWH-019, JWH-020, JWH-046, JWH-047, JWH-048, JWH-049, JWH-050, JWH-070, JWH-071, JWH-072, JWH-073, JWH-076, JWH-079, JWH-080, JWH-081, JWH-082, JWH-094, JWH-096, JWH-098, JWH-116, JWH-120, JWH-122, JWH-148, JWH-149, JWH-175, JWH-180, JWH-181, JWH-182, JWH-184, JWH-185, JWH-189, JWH-192, JWH-193, JWH-194, JWH-195, JWH-196, JWH-197, JWH-199, JWH-200, JWH-210, JWH-211, JWH-212, JWH-213, JWH-234, JWH-235, JWH-236, JWH-239, JWH-240, JWH-241, JWH-242, JWH-262, JWH-386, JWH-387, JWH-394, JWH-395, JWH-397, JWH-398, JWH-399, JWH-400, JWH-412, JWH-413, JWH-414 and JWH-415.
(iii) 3-naphthoyl-indazole or 3-(naphthylmethane)-indazole by substitution at one or both of the nitrogen atoms of the indazole ring, whether or not further substituted on the indazole ring to any extent, whether or not substituted on the naphthoyl ring to any extent.
Substances in the 3-naphthoyl-indazole or 3-(naphthylmethane)-indazole generic definition include THJ2201 and THJ-018.
- 3 - H.B.
2253 (iv) 3-(naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted on the naphthoyl ring to any extent.
Substances in the 3-(naphthoyl)pyrrole generic definition include JWH-030, JWH-145, JWH-146, JWH-147, JWH-150, JWH-156, JWH-243, JWH-244, JWH-245, JWH-246, JWH-292, JWH-293, JWH-307, JWH-308, JWH-346, JWH-348, JWH-363, JWH-364, JWH-365, JWH-367, JWH-368, JWH-369, JWH-370, JWH-371, JWH-373 and JWH-392.
(v) 1-(naphthylmethylene)indene by substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent.
Substances in the 1-(naphthylmethylene)indene generic definition include JWH-176.
(vi) 3-(phenylacetyl)indole or 3-(benzoyl)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent.
Substances in the 3-(phenylacetyl)indole generic definition include AM-694, AM-2233, JWH-167, JWH-201, JWH-202, JWH-203, JWH-204, JWH-205, JWH-206, JWH-207, JWH-208, JWH-209, JWH--237, JWH-248, JWH-250, JWH-251, JWH-253, JWH-302, JWH-303, JWH-304, JWH-305, JWH-306, JWH-311, JWH-312, JWH-313, JWH-314, JWH-315, JWH-316, RCS-4, RCS-8, SR-18 and SR-19.
(vii) 3-(cyclopropylmethanone) indole or 3-(cyclobutylmethanone) indole or 3-(cyclopentylmethanone) indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the cyclopropyl, cyclobutyl or cyclopentyl rings to any extent.
Substances in the 3-(cyclopropylmethanone) indole generic definition include UR-144, fluoro-UR-144 and XLR-11.
(viii) 3-adamantoylindole with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the adamantyl ring to any extent.
Substances in the 3-adamantoylindole generic definition include AB-001.
(ix) N-(adamantyl)-indole-3-carboxamide with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the adamantyl ring to any extent.
Substances in the N-(adamantyl)-indole-3-carboxamide generic definition include SDB-001.
(x) Indole-3-carboxamide or indazole-3-carboxamide with substitution at the nitrogen atom of the indole ring or by substitution at one or both of the nitrogen atoms of the indazole ring, whether or not further substituted on the indole ring or the indazole ring to any extent, whether or not substituted on the nitrogen of the carboxamide to any extent.
Substances in the indole-3-carboxamide or indazole-3-carboxamide - 4 - H.B.
2253 generic definition include AKB-48, fluoro-AKB-48, APINACA, AB-PINACA, AB-FUBINACA, ABICA and ADBICA.
(xi) 8-Quinolinyl-indole-3-carboxylate or 8-quinolinyl-indazole-3- carboxylate by substitution at the nitrogen atom of the indole ring or by substitution at one or both of the nitrogen atoms of the indazole ring, whether or not further substituted in the indole ring or indazole ring to any extent, whether or not substituted on the quinoline ring to any extent.
Substances in the 8-quinolinyl-indole-3-carboxylate or the 8-quinolinyl-indazole-3-carboxylate generic definition include PB-22, fluoro-PB-22, NPB-22 and fluoro-NPB-22.
(xii) Naphthalenyl-indole-3-carboxylate or naphthalenyl-indazole-3- carboxylate by substitution at the nitrogen atom of the indole ring or by substitution at one or both of the nitrogen atoms of the indazole ring, whether or not further substituted in the indole or indazole ring to any extent, whether or not substituted on the naphthalenyl ring to any extent.
Substances in the naphthalenyl-indole-3-carboxylate or naphthalenyl-indazole-3-carboxylate generic definition include NM2201, FDU-PB-22, SDB-005 and fluoro SDB-005.
(c) Any material, compound, mixture or preparation that contains any quantity of the following substances and their salts, isomers, whether optical, positional or geometric, and salts of isomers having a potential for abuse associated with a stimulant effect on the central nervous system:
(i) Alpha-pyrrolidinobutiophenone (Alpha-PBP).
(ii) Alpha-pyrrolidinopropiophenone (Alpha-PPP).
(iii) Alpha-pyrrolidinovalerophenone (Alpha-PVP).
(iv) Alpha-pyrrolidinovalerothiophenone (Alpha-PVT).
(v) Aminoindane mimetic substances that are derived from aminoindane by any substitution at the indane ring, replacement of the amino group with another N group or any combination of the above.
Substances in the aminoindane generic definition include MDAI, MMAI, IAI and AMMI.
(vi) Amphetamine.
(vii) Benzphetamine.
(viii) Benzylpiperazine (BZP).
(ix) Beta-keto-n-methylbenzodioxolylbutanamine (Butylone).
(x) Beta-keto-n-methylbenzodioxolylpentanamine (Pentylone).
(xi) Butorphanol.
(xii) Cathine ((+)-norpseudoephedrine).
(xiii) Cathinomimetic substances that are any substances derived from cathinone, (2-amino-1-phenyl-1-propanone) by any substitution at the phenyl ring, any substitution at the 3 position, any substitution at the nitrogen atom or any combination of the above substitutions.
(xiv) Cathinone.
(xv) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C).
- 5 - H.B.
2253 (xvi) Chlorphentermine.
(xvii) Clortermine.
(xviii) Diethylpropion.
(xix) Dihydro-5H-indeno-(5,6-d)-1,3-dioxol-6-amine) (MDAI).
(xx) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).
(xxi) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).
(xxii) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N).
(xxiii) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).
(xxiv) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H).
(xxv) Dimethylcathinone (Metamfepramone).
(xxvi) Ethcathinone.
(xxvii) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2).
(xxviii) Fencamfamin.
(xxix) Fenethylline.
(xxx) Fenproporex.
(xxxi) Fluoroamphetamine.
(xxxii) Fluoromethamphetamine.
(xxxiii) Fluoromethcathinone.
(xxxiv) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I).
(xxxv) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine(2C-T-4).
(xxxvi) Mazindol.
(xxxvii) Mefenorex.
(xxxviii) Methamphetamine.
(xxxix) Methcathinone.
(xl) Methiopropamine.
(xli) Methoxy-alpha-pyrrolidinopropiophenone (MOPPP).
(xlii) Methoxymethcathinone (methedrone).
(xliii) Methoxyphenethylamine mimetic substances that are any substances derived from 2, 5-dimethoxy-phenethylamine by any substitution at the phenyl ring, any substitution at the nitrogen atom, any substitutions at the carbon atoms of the ethylamine, or any combination of the above substitutions.
(xliv) 4-methylaminorex.
(xlv) Methyl-a-pyrrolidinobutiophenone (MPBP).
(xlvi) Methylenedioxy-alphapyrrolidinopropiophenone (MDPPP).
(xlvii) Methylenedioxyethcathinone (Ethylone).
(xlviii) Methylenedioxymethcathinone (Methylone).
(xlix) Methylenedioxypyrovalerone (MDPV).
(l) Methylmethcathinone (Mephedrone).
(li) Methylphenidate.
(lii) Modafinil.
(liii) Naphthylpyrovalerone (Naphyrone).
(liv) N-ethylamphetamine.
(lv) N, N-dimethylamphetamine.
- 6 - H.B.
2253 (lvi) Pemoline.
(lvii) Phendimetrazine.
(lviii) Phenmetrazine.
(lix) Phentermine.
(lx) Pipradol.
(lxi) Propylhexedrine.
(lxii) Pyrovalerone.
(lxiii) Sibutramine.
(lxiv) Spa ((-)-1-dimethylamino-1,2-diphenylethane).
(d) Any material, compound, mixture or preparation that contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system:
(i) Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, unless specifically excepted.
(ii) Alprazolam.
(iii) Bromazepam.
(iv) Camazepam.
(v) Carisoprodol.
(vi) Chloral betaine.
(vii) Chloral hydrate.
(viii) Chlordiazepoxide.
(ix) Chlorhexadol.
(x) Clobazam.
(xi) Clonazepam.
(xii) Clorazepate.
(xiii) Clotiazepam.
(xiv) Cloxazolam.
(xv) Delorazepam.
(xvi) Diazepam.
(xvii) Dichloralphenazone.
(xviii) Estazolam.
(xix) Ethchlorvynol.
(xx) Ethinamate.
(xxi) Ethyl loflazepate.
(xxii) Etizolam.
(xxiii) Fenfluramine.
(xxiv) Fludiazepam.
(xxv) Flunitrazepam.
(xxvi) Flurazepam.
(xxvii) Gamma hydroxy butyrate.
(xxviii) Glutethimide.
(xxix) Halazepam.
(xxx) Haloxazolam.
(xxxi) Hydroxyphencyclidine (HO-PCP).
- 7 - H.B.
2253 (xxxii) Ketamine.
(xxxiii) Ketazolam.
(xxxiv) Loprazolam.
(xxxv) Lorazepam.
(xxxvi) Lormetazepam.
(xxxvii) Lysergic acid.
(xxxviii) Mebutamate.
(xxxix) Mecloqualone.
(xl) Medazepam.
(xli) Meprobamate.
(xlii) Methaqualone.
(xliii) Methohexital.
(xliv) 2-(methoxyphenyl)-2-(ethylamino)cyclohexanone (Methoxetamine).
(xlv) 2-(methoxyphenyl)-2-(methylamino)cyclohexanone (Methoxyketamine).
(xlvi) Methoxyphencyclidine(MeO-PCP).
(xlvii) Methyprylon.
(xlviii) Midazolam.
(xlix) Nimetazepam.
(l) Nitrazepam.
(li) Nordiazepam.
(lii) Oxazepam.
(liii) Oxazolam.
(liv) Paraldehyde.
(lv) Petrichloral.
(lvi) Phencyclidine (PCP).
(lvii) Phencyclidine mimetic substances that are any substances derived from phenylcyclohexylpiperidine by any substitution at the phenyl ring, any substitution at the piperidine ring, any substitution at the cyclohexyl ring, any replacement of the phenyl ring or any combination of the above.
Substances in the phenylcyclohexylpiperidine generic definition include Amino-PCP, BCP, Bromo-PCP, BTCP, Chloro-PCP, Fluoro-PCP, HO-PCP, MeO-PCP, Methyl-PCP, Nitro-PCP, Oxo-PCP, PCE, PCM, PCPY, TCP and TCPY.
(lviii) Pinazepam.
(lix) Prazepam.
(lx) Scopolamine.
(lxi) Sulfondiethylmethane.
(lxii) Sulfonethylmethane.
(lxiii) Sulfonmethane.
(lxiv) Quazepam.
(lxv) Temazepam.
(lxvi) Tetrazepam.
(lxvii) Tiletamine.
- 8 - H.B.
2253 (lxviii) Triazolam.
(lxix) Zaleplon.
(lxx) Zolazepam.
(lxxi) Zolpidem.
(lxxii) Zopiclone.
(e) Any material, compound, mixture or preparation that contains any quantity of the following anabolic steroids and their salts, isomers or esters:
(i) Boldenone.
(ii) Clostebol (4-chlorotestosterone).
(iii) Dehydrochloromethyltestosterone.
(iv) Drostanolone.
(v) Ethylestrenol.
(vi) Fluoxymesterone.
(vii) Formebulone (formebolone).
(viii) Mesterolone.
(ix) Methandriol.
(x) Methandrostenolone (methandienone).
(xi) Methenolone.
(xii) Methyltestosterone.
(xiii) Mibolerone.
(xiv) Nandrolone.
(xv) Norethandrolon.
(xvi) Oxandrolone.
(xvii) Oxymesterone.
(xviii) Oxymetholone.
(xix) Stanolone (4-dihydrotestosterone).
(xx) Stanozolol.
(xxi) Testolactone.
(xxii) Testosterone.
(xxiii) Trenbolone.
THE SPECIFIC ASBESTOS-RELATED DISEASE CLAIMED TO EXIST.
"Deliver" means the actual, constructive or attempted exchange from one person to another, whether or not there is an agency relationship.
ANY SUPPORTING DOCUMENTATION RELATING TO THE INFORMATION REQUIRED BY THIS SUBSECTION.
"Director" means the director of the department of health services.
B.
9.
A PLAINTIFF HAS A CONTINUING DUTY TO SUPPLEMENT THE INFORMATION THAT IS REQUIRED TO BE DISCLOSED PURSUANT TO SUBSECTION A OF THIS SECTION.
"Dispense" means distribute, leave with, give away, dispose of or deliver.
C.
10.
ON MOTION BY A DEFENDANT, THE COURT SHALL DISMISS A PLAINTIFF'S CLAIM WITHOUT PREJUDICE AS TO ANY DEFENDANT WHOSE PRODUCT OR PREMISES IS NOT IDENTIFIED IN THE REQUIRED DISCLOSURES SET FORTH IN SUBSECTION A OF THIS SECTION.
"Drug court program" means a program that is established pursuant to section 13-3422 by the presiding judge of the superior court in cooperation with the county attorney in a county for the purpose of prosecuting, adjudicating and treating drug dependent persons who meet the criteria and guidelines for entry into the program that are developed and agreed on by the presiding judge and the prosecutor.
D.
- 9 - H.B.
ON MOTION BY A DEFENDANT, THE COURT SHALL DISMISS A PLAINTIFF'S CLAIM WITHOUT PREJUDICE AS TO ALL DEFENDANTS IF THE PLAINTIFF FAILS TO COMPLY WITH THE REQUIREMENTS OF THIS SECTION.
2253 11.
E.
"Drug dependent person" means a person who is using a substance that is listed in paragraph 6, 19, 20, 21 or 28 of this section and who is in a state of psychological or physical dependence, or both, arising from the use of that substance.
FOR THE PURPOSES OF THIS SECTION, "PERSONAL INJURY CLAIM" HAS THE SAME MEANING PRESCRIBED IN SECTION 12-782.
12.
Sec.
"Federal act" has the same meaning prescribed in section 32-1901.
2.
13.
Applicability Section 12-783, Arizona Revised Statutes, as added by this act, applies to personal injury claims arising from exposure to asbestos that are filed on or after the effective date of this act.
"Isoamidone" means any substance identified chemically as (4-4-diphenyl-5-methyl-6-dimethylaminohexanone-3), or any salt of such substance, by whatever trade name designated.
- 1 -
14.
"Isonipecaine" means any substance identified chemically as (1-methyl-4-phenyl-piperidine-4-carboxylic acid ethyl ester), or any salt of such substance, by whatever trade name designated.
15.
"Ketobemidone" means any substance identified chemically as (4-(3-hydroxyphenyl)-1-methyl-4-piperidylethyl ketone hydrochloride), or any salt of such substance, by whatever trade name designated.
16.
"Licensed" or "permitted" means authorized by the laws of this state to do certain things.
17.
"Manufacture" means produce, prepare, propagate, compound, mix or process, directly or indirectly, by extraction from substances of natural origin or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis.
Manufacture includes any packaging or repackaging or labeling or relabeling of containers.
Manufacture does not include any producing, preparing, propagating, compounding, mixing, processing, packaging or labeling done in conformity with applicable state and local laws and rules by a licensed practitioner incident to and in the course of his licensed practice.
18.
"Manufacturer" means a person who manufactures a narcotic or dangerous drug or other substance controlled by this chapter.
19.
"Marijuana" means all parts of any plant of the genus cannabis, from which the resin has not been extracted, whether growing or not, and the seeds of such plant.
Marijuana does not include the mature stalks of such plant or the sterilized seed of such plant which is incapable of germination.
20.
"Narcotic drugs" means the following, whether of natural or synthetic origin and any substance neither chemically nor physically distinguishable from them:
(a) Acetyl-alpha-methylfentanyl.
(b) Acetylmethadol.
(c) Alfentanil.
(d) Allylprodine.
(e) Alphacetylmethadol.
(f) Alphameprodine.
(g) Alphamethadol.
(h) Alpha-methylfentanyl.
(i) Alpha-methylthiofentanyl.
- 10 - H.B.
2253 (j) Alphaprodine.
(k) Amidone (methadone).
(l) Anileridine.
(m) Benzethidine.
(n) Benzylfentanyl.
(o) Betacetylmethadol.
(p) Beta-hydroxyfentanyl.
(q) Beta-hydroxy-3-methylfentanyl.
(r) Betameprodine.
(s) Betamethadol.
(t) Betaprodine.
(u) Bezitramide.
(v) Buprenorphine and its salts.
(w) Cannabis.
(x) Carfentanil.
(y) 4-chloro-n-[-1-[2-(4-nitrophenyl)ethyl]-2-piperidinylidene]benz enesulfonamide (W-18).
(z) 4-chloro-n-[1-(2-pheylethyl)-2-piperidinylidene] benzenesulfonamide (W-15).
(aa) Clonitazene.
(bb) Coca leaves.
(cc) 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45).
(dd) Dextromoramide.
(ee) Dextropropoxyphene.
(ff) Diampromide.
(gg) 3,4-dichloro-n-(-[1-(dimethylamino)cyclohexyl]methyl)-benzamid e (AH-7921).
(hh) 3,4-dichloro-n-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700).
(ii) Diethylthiambutene.
(jj) Difenoxin.
(kk) Dihydrocodeine.
(ll) Dimenoxadol.
(mm) Dimepheptanol.
(nn) Dimethylthiambutene.
(oo) Dioxaphetyl butyrate.
(pp) Diphenidine (DEP).
(qq) Diphenoxylate.
(rr) Dipipanone.
(ss) Ephenidine.
(tt) Ethylmethylthiambutene.
(uu) Etonitazene.
(vv) Etoxeridine.
(ww) Fentanyl.
- 11 - H.B.
2253 (xx) Fentanyl mimetic substances that are any substances derived from fentanyl by any substitution in the phenethyl group, any substitution in the piperidine ring, any substitution in the aniline ring, any replacement of the phenyl portion of the phenethyl group, any replacement of the N-propionyl group or any combination of the above.
(yy) Furethidine.
(zz) Hydroxypethidine.
(aaa) Isoamidone (isomethadone).
(bbb) Isophenidine.
(ccc) Pethidine (meperidine).
(ddd) Ketobemidone.
(eee) Lefetamine.
(fff) Levomethorphan.
(ggg) Levomoramide.
(hhh) Levophenacylmorphan.
(iii) Levorphanol.
(jjj) Metazocine.
(kkk) Methoxphenidine (MXP).
(lll) 3-methylfentanyl.
(mmm) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP).
(nnn) 3-methylthiofentanyl.
(ooo) Morpheridine.
(ppp) Noracymethadol.
(qqq) Norlevorphanol.
(rrr) Normethadone.
(sss) Norpipanone.
(ttt) Opium.
(uuu) Para-fluorofentanyl.
(vvv) Pentazocine.
(www) Phenadoxone.
(xxx) Phenampromide.
(yyy) Phenazocine.
(zzz) 1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine (PEPAP).
(aaaa) Phenomorphan.
(bbbb) Phenoperidine.
(cccc) Piminodine.
(dddd) Piritramide.
(eeee) Proheptazine.
(ffff) Properidine.
(gggg) Propiram.
(hhhh) Racemethorphan.
(iiii) Racemoramide.
(jjjj) Racemorphan.
(kkkk) Remifentanil.
(llll) Sufentanil.
- 12 - H.B.
2253 (mmmm) Thenylfentanyl.
(nnnn) Thiofentanyl.
(oooo) Tilidine.
(pppp) Tramadol, 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl) cyclohexanol, and its salts, optical and geometric isomers, and its salts of isomers.
(qqqq) Trimeperidine.
21.
"Opium" means any compound, manufacture, salt, isomer, salt of isomer, derivative, mixture or preparation of the following, but does not include apomorphine or any of its salts:
(a) Acetorphine.
(b) Acetyldihydrocodeine.
(c) Benzylmorphine.
(d) Codeine.
(e) Codeine methylbromide.
(f) Codeine-N-oxide.
(g) Cyprenorphine.
(h) Desomorphine.
(i) Dihydromorphine.
(j) Drotebanol.
(k) Ethylmorphine.
(l) Etorphine.
(m) Heroin.
(n) Hydrocodone.
(o) Hydromorphinol.
(p) Hydromorphone.
(q) Levo-alphacetylmethadol.
(r) Methyldesorphine.
(s) Methyldihydromorphine.
(t) Metopon.
(u) Morphine.
(v) Morphine methylbromide.
(w) Morphine methylsulfonate.
(x) Morphine-N-oxide.
(y) Myrophine.
(z) Nalorphine.
(aa) Nicocodeine.
(bb) Nicomorphine.
(cc) Normorphine.
(dd) Oxycodone.
(ee) Oxymorphone.
(ff) Pholcodine.
(gg) Thebacon.
(hh) Thebaine.
- 13 - H.B.
2253 22.
"Ordinary ephedrine, pseudoephedrine, (-)-norpseudoephedrine or phenylpropanolamine product" means a product that contains ephedrine, pseudoephedrine, (-)-norpseudoephedrine or phenylpropanolamine and that is all of the following:
(a) Approved for sale under the federal act.
(b) Labeled, advertised and marketed only for an indication that is approved by the federal food and drug administration.
(c) Either:
(i) A nonliquid that is sold in package sizes of not more than three grams of ephedrine, pseudoephedrine, (-)-norpseudoephedrine or phenlypropanolamine and that is packaged in blister packs containing not more than two dosage units or, if the use of blister packs is technically infeasible, that is packaged in unit dose packets or pouches.
(ii) A liquid that is sold in package sizes of not more than three grams of ephedrine, pseudoephedrine, (-)-norpseudoephedrine or phenylpropanolamine.
23.
"Peyote" means any part of a plant of the genus lophophora, known as the mescal button.
24.
"Pharmacy" means a licensed business where drugs are compounded or dispensed by a licensed pharmacist.
25.
"Practitioner" means a person licensed to prescribe and administer drugs.
26.
"Precursor chemical I" means any material, compound, mixture or preparation which contains any quantity of the following substances and their salts, optical isomers or salts of optical isomers:
(a) N-acetylanthranilic acid.
(b) Anthranilic acid.
(c) Ephedrine.
(d) Ergotamine.
(e) Isosafrole.
(f) Lysergic acid.
(g) Methylamine.
(h) N-ethylephedrine.
(i) N-ethylpseudoephedrine.
(j) N-methylephedrine.
(k) N-methylpseudoephedrine.
(l) Norephedrine.
(m) (-)-Norpseudoephedrine.
(n) Phenylacetic acid.
(o) Phenylpropanolamine.
(p) Piperidine.
(q) Pseudoephedrine.
- 14 - H.B.
2253 27.
"Precursor chemical II" means any material, compound, mixture or preparation which contains any quantity of the following substances and their salts, optical isomers or salts of optical isomers:
(a) 4-cyano-2-dimethylamino-4, 4-diphenyl butane.
(b) 4-cyano-1-methyl-4-phenylpiperidine.
(c) Chlorephedrine.
(d) Chlorpseudoephedrine.
(e) Ethyl-4-phenylpiperidine-4-carboxylate.
(f) 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid.
(g) 1-methyl-4-phenylpiperidine-4-carboxylic acid.
(h) N-formyl amphetamine.
(i) N-formyl methamphetamine.
(j) Phenyl-2-propanone.
(k) 1-piperidinocyclohexane carbonitrile.
(l) 1-pyrrolidinocyclohexane carbonitrile.
28.
"Prescription-only drug" does not include a dangerous drug or narcotic drug but means:
(a) Any drug which because of its toxicity or other potentiality for harmful effect, or the method of its use, or the collateral measures necessary to its use, is not generally recognized among experts, qualified by scientific training and experience to evaluate its safety and efficacy, as safe for use except by or under the supervision of a medical practitioner.
(b) Any drug that is limited by an approved new drug application under the federal act or section 32-1962 to use under the supervision of a medical practitioner.
(c) Every potentially harmful drug, the labeling of which does not bear or contain full and adequate directions for use by the consumer.
(d) Any drug required by the federal act to bear on its label the legend "Caution:
Federal law prohibits dispensing without prescription" or "Rx only".
29.
"Produce" means grow, plant, cultivate, harvest, dry, process or prepare for sale.
30.
"Regulated chemical" means the following substances in bulk form that are not a useful part of an otherwise lawful product:
(a) Acetic anhydride.
⬇ Download PDF
View plain text versions (8)

Action History

  1. Signed by Governor

  2. Transmit to Governor

  3. Transmit to House

  4. PASSED

  5. PASSED

  6. PASSED

  7. PASSED

  8. FAILED

  9. DPA

  10. DPA/SE

  11. Senate Second Reading

  12. Senate First Reading

  13. Transmit to Senate

  14. PASSED

  15. DPA

  16. DPA

  17. House Second Reading

  18. House First Reading.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 92 not signed on · 34 voted No

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (92)

92 members have not signed on to this bill.

Show all 92 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Passed

Passed 16 Yea · 12 Nay · 2 Other
Party YeaNayPresentNot Voting
Democrat 0302
Unaffiliated 9900
Republican 7000
Total 161202
% of votes cast 53%40%0%7%
How each member voted (30)
Member Party Vote
Christine Marsh — Nay
Juan Mendez — Nay
Karen Fann — Yea
Kelly Townsend — Yea
Lisa Otondo — Nay
Martin Quezada — Nay
Michelle B. Ugenti-Rita — Yea
Nancy Barto — Yea
Paul Boyer — Yea
Raquel Terán — Nay
Rebecca Rios — Nay
Rick Gray — Yea
Rosanna Gabaldon — Nay
Sean Bowie — Nay
Sine Kerr — Yea
Sonny Borrelli — Yea
Tyler Pace — Yea
Victoria Steele — Nay
Lela Alston Democrat Not Voting
Lupe Contreras Democrat Nay
Sally Ann Gonzales Democrat Not Voting
Stephanie Stahl Hamilton Democrat Nay
Theresa Hatathlie Democrat Nay
David Gowan Republican Yea
David Livingston Republican Yea
J.D. Mesnard Republican Yea
Thomas "T.J." Shope Republican Yea
Venden "Vince" Leach Republican Yea
Warren Petersen Republican Yea
Wendy Rogers Republican Yea

Official roll call →

failed to pass

Failed 14 Yea · 14 Nay · 2 Other
Party YeaNayPresentNot Voting
Democrat 0500
Unaffiliated 8802
Republican 6100
Total 141402
% of votes cast 47%47%0%7%
How each member voted (30)
Member Party Vote
Christine Marsh — Nay
Juan Mendez — Not Voting
Karen Fann — Yea
Kelly Townsend — Yea
Lisa Otondo — Nay
Martin Quezada — Nay
Michelle B. Ugenti-Rita — Yea
Nancy Barto — Yea
Paul Boyer — Nay
Raquel Terán — Nay
Rebecca Rios — Nay
Rick Gray — Yea
Rosanna Gabaldon — Not Voting
Sean Bowie — Nay
Sine Kerr — Yea
Sonny Borrelli — Yea
Tyler Pace — Yea
Victoria Steele — Nay
Lela Alston Democrat Nay
Lupe Contreras Democrat Nay
Sally Ann Gonzales Democrat Nay
Stephanie Stahl Hamilton Democrat Nay
Theresa Hatathlie Democrat Nay
David Gowan Republican Yea
David Livingston Republican Nay
J.D. Mesnard Republican Yea
Thomas "T.J." Shope Republican Yea
Venden "Vince" Leach Republican Yea
Warren Petersen Republican Yea
Wendy Rogers Republican Yea

Official roll call →

Passed

Passed 41 Yea · 18 Nay · 1 Other
Party YeaNayPresentNot Voting
Unaffiliated 201601
Republican 17000
Democrat 4200
Total 411801
% of votes cast 68%30%0%2%
How each member voted (60)
Member Party Vote
Amish Shah — Nay
Andrea Dalessandro — Nay
Andres Cano — Nay
Athena Salman — Not Voting
Ben Toma — Yea
Brenda Barton — Yea
Christian Solorio — Nay
César Chávez — Nay
Daniel Hernandez — Nay
David L. Cook — Yea
Diego Espinoza — Nay
Domingo DeGrazia — Yea
Jacqueline Parker — Yea
Jasmine Blackwater-Nygren — Yea
Jennifer Jermaine — Yea
Jennifer Longdon — Nay
Jennifer Pawlik — Yea
Joanne Osborne — Yea
Joel John — Yea
John Fillmore — Yea
Judy Burges — Yea
Judy Schwiebert — Nay
Kelli Butler — Nay
Lorenzo Sierra — Yea
Marcelino Quiñonez — Nay
Melody Hernandez — Nay
Michelle Udall — Yea
Morgan Abraham — Yea
Pamela Powers Hannley — Nay
Regina E. Cobb — Yea
Reginald Bolding — Nay
Richard C. Andrade — Nay
Robert Meza — Nay
Russell Bowers — Yea
Steve Kaiser — Yea
Travis W. Grantham — Yea
Walter Blackman — Yea
Alma Hernandez Democrat Yea
Brian Fernandez Democrat Yea
Christopher Mathis Democrat Yea
Denise “Mitzi” Epstein Democrat Nay
Myron Tsosie Democrat Yea
Sarah Liguori Democrat Nay
Beverly Pingerelli Republican Yea
Frank Carroll Republican Yea
Gail Griffin Republican Yea
Jake Hoffman Republican Yea
Jeff Weninger Republican Yea
John Kavanagh Republican Yea
Joseph Chaplik Republican Yea
Justin Wilmeth Republican Yea
Kevin Payne Republican Yea
Leo Biasiucci Republican Yea
Lupe Diaz Republican Yea
Mark Finchem Republican Yea
Neal Carter Republican Yea
Quang H Nguyen Republican Yea
Shawnna Bolick Republican Yea
Teresa Martinez Republican Yea
Timothy "Tim" Dunn Republican Yea

Official roll call →

Subjects

public-safety health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HB 2253?
HB 2253 is sponsored by Travis W. Grantham.
What is the current status of HB 2253?
This bill has been enacted into law. Introduced January 24, 2022. Enacted.
Where can I track HB 2253?
Track HB 2253 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 2253

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 2253

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →